Commenters seek details on RMAT designation
Regulatory NewsJeff Craven
Advanced therapies/cell and gene therapyClinical TrialsPharmaceuticalsProduct developmentUnited StatesRegulatory NewsJeff CravenAdvanced therapies/cell and gene therapyClinical TrialsPharmaceuticalsProduct developmentUnited States